Literature DB >> 26200936

Applications of Fluorine in Medicinal Chemistry.

Eric P Gillis1, Kyle J Eastman1, Matthew D Hill1, David J Donnelly2, Nicholas A Meanwell1.   

Abstract

The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties associated with this unusual element and how to deploy it with greater sophistication. The judicious introduction of fluorine into a molecule can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties. In addition, (18)F has been established as a useful positron emitting isotope for use with in vivo imaging technology that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compounds. The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compounds. In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug molecules and applications in positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200936     DOI: 10.1021/acs.jmedchem.5b00258

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  326 in total

Review 1.  Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.

Authors:  Allen F Brooks; Lindsey R Drake; Megan N Stewart; Brian P Cary; Isaac M Jackson; Dale Mallette; Andrew V Mossine; Peter J H Scott
Journal:  Pharm Pat Anal       Date:  2015-12-16

2.  Catalytic, Enantioselective 1,2-Difluorination of Cinnamamides.

Authors:  Moriana K Haj; Steven M Banik; Eric N Jacobsen
Journal:  Org Lett       Date:  2019-04-09       Impact factor: 6.005

3.  Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.

Authors:  Haifeng Tang; Yuping Zhu; Nardos Teumelsan; Shawn P Walsh; Aurash Shahripour; Birgit T Priest; Andrew M Swensen; John P Felix; Richard M Brochu; Timothy Bailey; Brande Thomas-Fowlkes; Lee-Yuh Pai; Caryn Hampton; Aaron Corona; Melba Hernandez; Joseph Metzger; Michael Forrest; Xiaoyan Zhou; Karen Owens; Vincent Tong; Emma Parmee; Sophie Roy; Gregory J Kaczorowski; Lihu Yang; Magdalena Alonso-Galicia; Maria L Garcia; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2016-05-12       Impact factor: 4.345

4.  Regio- and Enantioselective Bromocyclization of Difluoroalkenes as a Strategy to Access Tetrasubstituted Difluoromethylene-Containing Stereocenters.

Authors:  Edward Miller; Suhong Kim; Katarina Gibson; Jeffrey S Derrick; F Dean Toste
Journal:  J Am Chem Soc       Date:  2020-04-30       Impact factor: 15.419

Review 5.  Halogenase engineering and its utility in medicinal chemistry.

Authors:  Amy E Fraley; David H Sherman
Journal:  Bioorg Med Chem Lett       Date:  2018-04-30       Impact factor: 2.823

6.  Direct arene C-H fluorination with 18F- via organic photoredox catalysis.

Authors:  Wei Chen; Zeng Huang; Nicholas E S Tay; Benjamin Giglio; Mengzhe Wang; Hui Wang; Zhanhong Wu; David A Nicewicz; Zibo Li
Journal:  Science       Date:  2019-06-21       Impact factor: 47.728

7.  Generating Stereodiversity: Diastereoselective Fluorination and Highly Diastereoselective Epimerization of α-Amino Acid Building Blocks.

Authors:  Wei Wei; Rama Kanwar Khangarot; Lothar Stahl; Cristina Veresmortean; Padmanava Pradhan; Lijia Yang; Barbara Zajc
Journal:  Org Lett       Date:  2018-06-01       Impact factor: 6.005

8.  Copper-Mediated Aminoquinoline-Directed Radiofluorination of Aromatic C-H Bonds with K18 F.

Authors:  So Jeong Lee; Katarina J Makaravage; Allen F Brooks; Peter J H Scott; Melanie S Sanford
Journal:  Angew Chem Int Ed Engl       Date:  2019-01-18       Impact factor: 15.336

9.  Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.

Authors:  Matthew J Mitcheltree; Derun Li; Abdelghani Achab; Adam Beard; Kalyan Chakravarthy; Mangeng Cheng; Hyelim Cho; Padmanabhan Eangoor; Peter Fan; Symon Gathiaka; Hai-Young Kim; Charles A Lesburg; Thomas W Lyons; Theodore A Martinot; J Richard Miller; Spencer McMinn; Jennifer O'Neil; Anandan Palani; Rachel L Palte; Josep Saurí; David L Sloman; Hongjun Zhang; Jared N Cumming; Christian Fischer
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

10.  Electronically Activated Organoboron Catalysts for Enantioselective Propargyl Addition to Trifluoromethyl Ketones.

Authors:  Nicholas W Mszar; Malte S Mikus; Sebastian Torker; Fredrik Haeffner; Amir H Hoveyda
Journal:  Angew Chem Int Ed Engl       Date:  2017-06-21       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.